Focused Overview of the 2024 Global Initiative for Asthma Guidelines

Abstract

Asthma affects over 300 million people across the globe and involves chronic airway inflammation, reversible expiratory airflow limitation, and heightened airway responsiveness. Although asthma research and treatment have made substantial progress in recent years, both over- and under-diagnosis of asthma are frequent. In this overview, we highlight key updates from the 2024 Global Initiative for Asthma guidelines for optimal patient-centered asthma care. This article outlines the latest findings on asthma and its treatments, offering recommendations for evidence-based clinical practice.

Keywords

• asthma
• asthma management
• global initiative for asthma guidelines
• inhaled corticosteroids
• long-acting beta-agonist (laba)
• short-acting beta-agonist (saba)